Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.47 | - | - |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €91.68 | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.29 | €3.70 | 187.490% |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | €8.70 | €17.64 | 102.732% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.64 | €26.01 | 39.519% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €21.20 | €32.58 | 53.674% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €35.20 | €38.99 | 10.763% |
| PTC Therapeutics Inc. | 15 | 8 | 3 | 3 | €31.80 | €41.51 | 30.542% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €39.58 | €47.17 | 19.176% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €35.40 | €84.74 | 139.390% |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | €123.95 | €140.60 | 13.436% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €140.00 | €184.76 | 31.971% |
| United Therapeutics | 19 | 0 | 4 | 0 | €247.50 | €287.40 | 16.122% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €358.90 | €419.64 | 16.923% |